1-2 of 2
specific autoantibodies seen in polymyositis or dermatomyositis (e.g., pm1, jo, me, etc)
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial

Jason Gotlib, MD, Hanneke C. Kluin-Nelemans, MD, PhD, Tracy I. George, MD, Cem Akin, MD, PhD, Karl Sotlar, MD, Olivier Hermine, Farrukh Awan, MD, MS, Elizabeth Hexner, MD, Michael Mauro, MD, Rodica Morariu, MD, Margaret Squier, MD, PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, John Coombs, PharmD, MBA, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD
Journal: Blood
Blood (2013) 122 (21): 106.
https://doi.org/10.1182/blood.V122.21.106.106
Published: 2013
Journal Articles

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF).

Ruben A. Mesa, MD, FACP, Susan Schwager, Deepti Radia, MD, Andrea Cheville, MD, Kebede Hussein, MD, Joyce Niblack, JD, Animesh D. Pardanani, MBBS, PhD, David P. Steensma, MD, FACP, Mark R. Litzow, MD, Candido E. Rivera, MD, John Camoriano, MD, Srdan Verstovsek, Jeffrey Sloan, PhD, Claire Harrison, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2008) 112 (11): 1754.
https://doi.org/10.1182/blood.V112.11.1754.1754
Published: 2008